Wednesday, 8 July 2009

Letairis


Letairis is a brand name of ambrisentan, approved by the FDA in the following formulation(s):


LETAIRIS (ambrisentan - tablet; oral)



  • Manufacturer: GILEAD

    Approval date: June 15, 2007

    Strength(s): 10MG [RLD], 5MG

Has a generic version of Letairis been approved?


No. There is currently no therapeutically equivalent version of Letairis available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Letairis. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • 3-(Het) arylcarboxylic acid derivatives, their preparation and intermediates for their preparation
    Patent 5,703,017
    Issued: December 30, 1997
    Inventor(s): Baumann; Ernst & Rheinheimer; Joachim & Vogelbacher; Uwe Josef & Bratz; Matthias & Theobald; Hans & Gerber; Matthias & Westphalen; Karl-Otto & Walter; Helmut & Rademacher; Wilhelm
    Assignee(s): BASF Aktiengesellschaft
    3-(Het)arylcarboxylic acid derivatives of the formula I ##STR1## where R is formyl, CO.sub.2 H or a radical hydrolyzable to COOH and the other substituents have the following meanings: R.sup.2 and R.sup.3 are each halogen, alkyl, haloalkyl, alkoxy, haloalkoxy or alkylthio; X is nitrogen or CR.sup.14, where R.sup.14 is hydrogen or, together with R.sup.3, forms an alkylene or alkenylene chain, in each of which a methylene group is replaced by oxygen; R.sup.4 is phenyl or naphthyl, each of which is unsubstituted or substituted or an unsubstituted or substituted five-membered or six-membered heteroaromatic structure containing one to three nitrogen atoms or one sulfur or oxygen atom; R.sup.5 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, haloalkyl, alkoxyalkyl, alkylthioalkyl or phenyl; R.sup.6 is C.sub.1 -C.sub.8 -alkyl, C.sub.3 -C.sub.6 -alkenyl, C.sub.3 -C.sub.6 -alkynyl or C.sub.3 -C.sub.4 -cyclo-alkyl, each of which may be mono- or polysubstituted; Y is sulfur, oxygen or a single bond; and Z is sulfur or oxygen; with the proviso that R.sup.6 is not unsubstituted C.sub.1 -C.sub.4 -alkyl when R.sup.4 is unsubstituted phenyl, Z is oxygen and simultaneously R.sup.5 is methyl or hydrogen.
    Patent expiration dates:

    • December 30, 2014
      ✓ 
      Drug substance




  • Use of carboxylic acid derivatives as drugs
    Patent 5,840,722
    Issued: November 24, 1998
    Inventor(s): Baumann; Ernst & Vogelbacher; Uwe Josef & Rheinheimer; Joachim & Klinge; Dagmar & Riechers; Hartmut & Kroger; Burkhard & Bialojan; Siegfried & Bollschweiler; Claus & Wernet; Wolfgang & Unger; Liliane & Raschack; Manfred
    Assignee(s): BASF Aktiengesellschaft
    A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I ##STR1##
    Patent expiration dates:

    • November 24, 2015
      ✓ 
      Patent use: METHOD OF INHIBITING ENTHOTHELIN RECEPTORS BY ADMINISTERING AMBRISENTAN TO A PATIENT TO TREAT PULMONARY ARTERIAL HYPERTENSION.




  • Carboxylic acid derivatives, their preparation and use
    Patent 7,109,205
    Issued: September 19, 2006
    Inventor(s): Riechers; Hartmut & Klinge; Dagmar & Amberg; Wilhelm & Kling; Andreas & Müller; Stefan & Baumann; Ernst & Rheinheimer; Joachim & Vogelbacher; Uwe Josef & Wernet; Wolfgang & Unger; Liliane & Raschack; Manfred
    Assignee(s): Abbott GmbH & Co. KG
    Carboxylic acid derivatives where R–R6, X, Y and Z have the meanings stated in the description, and the preparation thereof, are described. The novel compounds are suitable for controlling diseases.
    Patent expiration dates:

    • October 7, 2015
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Carboxylic acid derivatives, their preparation and use
    Patent 7,601,730
    Issued: October 13, 2009
    Inventor(s): Riechers; Hartmut & Klinge; Dagmar & Amberg; Wilhelm & Kling; Andreas & Muller; Stefan & Baumann; Ernst & Rheinheimer; Joachim & Vogelbacher; Uwe Josef & Wernet; Wolfgang & Unger; Liliane & Raschack; Manfred
    Assignee(s): Abbott GmbH & Co. KG
    Carboxylic acid derivatives where R—R6, X, Y and Z have the meanings stated in the description, and the preparation thereof, are described. The novel compounds are suitable for controlling diseases.
    Patent expiration dates:

    • October 7, 2015
      ✓ 
      Patent use: METHOD TO TREAT PULMONARY HYPERTENSION BY ADMINISTERING AMBRISENTAN TO A PATIENT




  • Carboxylic acid derivatives, their preparation and use
    Patent RE42462
    Issued: June 14, 2011
    Inventor(s): Riechers; Hartmut & Klinge; Dagmar & Amberg; Wilhelm & Kling; Andreas & Muller; Stefan & Baumann; Ernst & Rheinheimer; Joachim & Vogelbacher; Uwe Josef & Wernet; Wolfgang & Unger; Liliane & Raschack; Manfred
    Assignee(s): Abbott GmbH & Co. KG
    Carboxylic acid derivatives where R-R6, X, Y and Z have the meanings stated in the description, and the preparation thereof, are described. The novel compounds are suitable for controlling diseases.
    Patent expiration dates:

    • October 7, 2015
      ✓ 
      Drug substance



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • June 15, 2012 - NEW CHEMICAL ENTITY

    • June 15, 2014 - ORPHAN DRUG EXCLUSIVITY

See also...

  • Letairis Consumer Information (Drugs.com)
  • Letairis Consumer Information (Wolters Kluwer)
  • Letairis Consumer Information (Cerner Multum)
  • Letairis Advanced Consumer Information (Micromedex)
  • Letairis AHFS DI Monographs (ASHP)
  • Ambrisentan Consumer Information (Wolters Kluwer)
  • Ambrisentan Consumer Information (Cerner Multum)
  • Ambrisentan Advanced Consumer Information (Micromedex)
  • Ambrisentan AHFS DI Monographs (ASHP)

Sunday, 5 July 2009

ProAmatine


ProAmatine is a brand name of midodrine, approved by the FDA in the following formulation(s):


PROAMATINE (midodrine hydrochloride - tablet; oral)



  • Manufacturer: SHIRE LLC

    Approval date: September 6, 1996

    Strength(s): 2.5MG [AB], 5MG [RLD][AB]


  • Manufacturer: SHIRE LLC

    Approval date: March 20, 2002

    Strength(s): 10MG [AB]

Has a generic version of ProAmatine been approved?


Yes. The following products are equivalent to ProAmatine:


midodrine hydrochloride tablet; oral



  • Manufacturer: APOTEX INC

    Approval date: September 12, 2006

    Strength(s): 10MG [AB], 2.5MG [AB], 5MG [AB]


  • Manufacturer: IMPAX PHARMS

    Approval date: May 27, 2004

    Strength(s): 2.5MG [AB], 5MG [AB]


  • Manufacturer: IMPAX PHARMS

    Approval date: December 16, 2005

    Strength(s): 10MG [AB]


  • Manufacturer: MYLAN

    Approval date: September 10, 2003

    Strength(s): 10MG [AB], 2.5MG [AB], 5MG [AB]


  • Manufacturer: SANDOZ

    Approval date: September 11, 2003

    Strength(s): 2.5MG [AB], 5MG [AB]


  • Manufacturer: SANDOZ

    Approval date: July 2, 2004

    Strength(s): 10MG [AB]

ORVATEN (midodrine hydrochloride tablet; oral)



  • Manufacturer: UPSHER SMITH

    Approval date: November 3, 2004

    Strength(s): 10MG [AB], 2.5MG [AB], 5MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of ProAmatine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with ProAmatine.

See also...

  • ProAmatine Consumer Information (Wolters Kluwer)
  • ProAmatine Consumer Information (Cerner Multum)
  • Proamatine Advanced Consumer Information (Micromedex)
  • Midodrine Consumer Information (Wolters Kluwer)
  • Midodrine Consumer Information (Cerner Multum)
  • Midodrine Advanced Consumer Information (Micromedex)
  • Midodrine Hydrochloride AHFS DI Monographs (ASHP)

Celeston Chronodose




Celeston Chronodose may be available in the countries listed below.


Ingredient matches for Celeston Chronodose



Betamethasone

Betamethasone 21-acetate (a derivative of Betamethasone) is reported as an ingredient of Celeston Chronodose in the following countries:


  • Luxembourg

  • Norway

International Drug Name Search

Saturday, 4 July 2009

Vasocidin


Vasocidin is a brand name of prednisolone/sulfacetamide sodium ophthalmic, approved by the FDA in the following formulation(s):


VASOCIDIN (prednisolone sodium phosphate; sulfacetamide sodium - solution/drops; ophthalmic)



  • Manufacturer: NOVARTIS

    Approval date: August 26, 1988

    Strength(s): EQ 0.23% PHOSPHATE;10% [RLD][AT]

Has a generic version of Vasocidin been approved?


Yes. The following products are equivalent to Vasocidin:


SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE (prednisolone sodium phosphate; sulfacetamide sodium solution/drops; ophthalmic)



  • Manufacturer: ALCON PHARMS LTD

    Approval date: May 27, 1993

    Strength(s): EQ 0.23% PHOSPHATE;10% [AT]


  • Manufacturer: BAUSCH AND LOMB

    Approval date: December 29, 1995

    Strength(s): EQ 0.23% PHOSPHATE;10% [AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vasocidin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Vasocidin.

See also...

  • Vasocidin Drops Consumer Information (Wolters Kluwer)
  • Vasocidin Consumer Information (Cerner Multum)
  • Prednisolone/Sulfacetamide Drops Consumer Information (Wolters Kluwer)
  • Prednisolone/Sulfacetamide Ointment Consumer Information (Wolters Kluwer)
  • Prednisolone/Sulfacetamide Suspension Consumer Information (Wolters Kluwer)
  • Sulfacetamide and prednisolone ophthalmic Consumer Information (Cerner Multum)

Friday, 26 June 2009

dextromethorphan, guaifenesin, and pseudoephedrine


Generic Name: dextromethorphan, guaifenesin, and pseudoephedrine (dex troe meth OR fan, gwye FEN e sin, soo doe e FED rin)

Brand names: Altarussin CF, Ambifed-G DM, Relacon-DM NR, Robitussin Cold and Cough, Robitussin Pediatric Cough and Decongestant, Suda-Tussin DM, Touro CC, Touro CC-LD, Tussafed-LA, ...show all 76 brand names.


What is dextromethorphan, guaifenesin, and pseudoephedrine?

Dextromethorphan is a cough suppressant. It affects the signals in the brain that trigger cough reflex.


Guaifenesin is an expectorant. It helps loosen congestion in your chest and throat, making it easier to cough out through your mouth.


Pseudoephedrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).


The combination of dextromethorphan, guaifenesin, and pseudoephedrine is used to treat stuffy nose, sinus congestion, cough, and chest congestion caused by the common cold or flu.


Dextromethorphan will not treat a cough that is caused by smoking, asthma, or emphysema.

Dextromethorphan, guaifenesin, and pseudoephedrine may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about dextromethorphan, guaifenesin, and pseudoephedrine?


Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Do not use a cough or cold medicine if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take cough or cold medicine before the MAO inhibitor has cleared from your body. Do not use any other over-the-counter cough, cold, allergy, or sleep medication without first asking your doctor or pharmacist. If you take certain products together you may accidentally take too much of one or more types of medicine. Read the label of any other medicine you are using to see if it contains a decongestant, expectorant, or cough suppressant. Dextromethorphan will not treat a cough that is caused by smoking, asthma, or emphysema.

What should I discuss with my healthcare provider before using dextromethorphan, guaifenesin, and pseudoephedrine?


Do not use a cough or cold medicine if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take cough or cold medicine before the MAO inhibitor has cleared from your body. Do not use this medicine if you are allergic to dextromethorphan, guaifenesin, or pseudoephedrine.

Before taking this medicine, tell your doctor if you are allergic to any drugs or if you have emphysema or chronic bronchitis. You may not be able to use this medication, or you may need a dosage adjustment or special tests during treatment.


This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. This medication may pass into breast milk and could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Artificially-sweetened liquid forms of cold medicine may contain phenylalanine. This would be important to know if you have phenylketonuria (PKU). Check the ingredients and warnings on the medication label if you are concerned about phenylalanine.


How should I take dextromethorphan, guaifenesin, and pseudoephedrine?


Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts, or use it for longer than recommended. Cold medicine is usually taken only for a short time until your symptoms clear up.


Always ask a doctor before giving cough or cold medicine to a child. Death can occur from the misuse of cough or cold medicine in very young children.

Measure the liquid form of this medicine with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


Take the medication with food if it upsets your stomach. Drink extra fluids to help loosen the congestion and lubricate your throat while you are taking this medication. Do not crush, chew, or break an extended-release tablet. Swallow the pill whole. It is specially made to release medicine slowly in the body. Breaking or opening the pill would cause too much of the drug to be released at one time. Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache, cough, or skin rash.

If you need to have any type of surgery, tell the surgeon ahead of time if you have taken a cold medicine within the past few days.


Store this medicine at room temperature, away from heat, light, and moisture.

See also: Dextromethorphan, guaifenesin, and pseudoephedrine dosage (in more detail)

What happens if I miss a dose?


Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at your next regularly scheduled time. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include feeling restless or nervous.


What should I avoid while taking dextromethorphan, guaifenesin, and pseudoephedrine?


This medication can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid drinking alcohol. It can increase some of the side effects of this medication.

Avoid taking diet pills, caffeine pills, or other stimulants (such as ADHD medications) without your doctor's advice. Taking a stimulant together with cough or cold medicine can increase your risk of unpleasant side effects.


Do not use any other over-the-counter cough, cold, allergy, or sleep medication without first asking your doctor or pharmacist. If you take certain products together you may accidentally take too much of one or more types of medicine. Read the label of any other medicine you are using to see if it contains a decongestant, expectorant, or cough suppressant.

Dextromethorphan, guaifenesin, and pseudoephedrine side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have any of these serious side effects:

  • severe dizziness, anxiety, restless feeling, or nervousness;




  • confusion, hallucinations; or




  • slow, shallow breathing.



Less serious side effects may include:



  • dizziness or headache,




  • a rash, or




  • nausea, vomiting, or stomach upset.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


Dextromethorphan, guaifenesin, and pseudoephedrine Dosing Information


Usual Adult Dose for Cough and Nasal Congestion:

Dextromethorphan/guaifenesin/pseudoephedrine 15 mg-150 mg-30 mg/5 mL oral syrup:
5 to 10 mL orally every 4 to 6 hours not to exceed 4 doses daily.

Dextromethorphan/guaifenesin/pseudoephedrine 15 mg-175 mg-30 mg/5 mL oral suspension:
10 mL orally 3 times daily not to exceed 3 doses daily.

Dextromethorphan/guaifenesin/pseudoephedrine 15 mg-175 mg-30 mg/5 mL oral suspension, extended release:
10 mL orally 2 times daily not to exceed 2 doses daily.

Dextromethorphan/guaifenesin/pseudoephedrine 15 mg-175 mg-32 mg/5 mL oral liquid:
Dextromethorphan/guaifenesin/pseudoephedrine 15 mg-200 mg-32 mg/5 mL oral liquid:
10 mL orally 2 to 3 times daily not to exceed 3 doses daily.

Dextromethorphan/guaifenesin/pseudoephedrine 15 mg-200 mg-30 mg/5 mL oral liquid:
10 mL orally every 4 hours not to exceed 4 doses daily.

Dextromethorphan/guaifenesin/pseudoephedrine 15 mg-400 mg-45 mg oral tablet:
1 tablet orally every 6 hours not to exceed 4 tablets daily.

Dextromethorphan/guaifenesin/pseudoephedrine 20 mg-400 mg-20 mg oral tablet:
1 tablet orally every 4 to 6 hours not to exceed 6 tablets daily.

Dextromethorphan/guaifenesin/pseudoephedrine 20 mg-400 mg-30 mg oral tablet:
1 tablet orally every 4 to 6 hours not to exceed 6 tablets daily.

Dextromethorphan/guaifenesin/pseudoephedrine 20 mg-400 mg-40 mg oral tablet:
1 tablet orally every 4 to 6 hours not to exceed 6 tablets daily.

Dextromethorphan/guaifenesin/pseudoephedrine 30 mg-575 mg-25 mg oral tablets, extended release:
1 to 2 tablets orally every 12 hours not to exceed 4 tablets daily.

Dextromethorphan/guaifenesin/pseudoephedrine 30 mg-580 mg-60 mg oral tablet, extended release:
1 to 2 tablets orally 2 times daily.

Dextromethorphan/guaifenesin/pseudoephedrine 30 mg-600 mg-50 mg oral tablets, extended release:
1 to 2 tablets orally every 12 hours not to exceed 4 tablets daily.

Dextromethorphan/guaifenesin/pseudoephedrine 40 mg-700 mg-80 mg oral tablet, extended release:
0.5 to 1.5 tablets orally every 12 hours.

Dextromethorphan/guaifenesin/pseudoephedrine 40 mg-780 mg-80 mg oral tablet, extended release:
0.5 to 1.5 tablets orally 2 times daily. 1 tablet orally 3 times daily for maximum dosage.

Dextromethorphan/guaifenesin/pseudoephedrine 60 mg-800 mg-120 mg oral tablets, extended release:
1 tablet orally every 12 hours not to exceed 2 tablets daily.

Usual Pediatric Dose for Cough and Nasal Congestion:

Dextromethorphan/guaifenesin/pseudoephedrine 15 mg-150 mg-30 mg/5 mL oral syrup:
6 to 11 years: 2.5 to 5 mL orally every 4 to 6 hours not to exceed 4 doses daily.
12 years or older: 5 to 10 mL orally every 4 to 6 hours not to exceed 4 doses daily.

Dextromethorphan/guaifenesin/pseudoephedrine 15 mg-175 mg-30 mg/5 mL oral suspension:
2 to 5 years: 2.5 mL orally 3 times daily not to exceed 3 doses daily.
6 to 11 years: 5 mL orally 3 times daily not to exceed 3 doses daily.
12 years or older: 10 mL orally 3 times daily not to exceed 3 doses daily.

Dextromethorphan/guaifenesin/pseudoephedrine 15 mg-175 mg-30 mg/5 mL oral suspension, extended release:
2 to 5 years: 2.5 mL orally 2 times daily not to exceed 4 mg/kg and up to a maximum of 60 mg of pseudoephedrine daily.
6 to 11 years: 5 mL orally 2 times daily not to exceed 2 doses daily..
12 years or older: 10 mL orally 2 times daily not to exceed 2 doses daily.

Dextromethorphan/guaifenesin/pseudoephedrine 15 mg-175 mg-32 mg/5 mL oral liquid:
Dextromethorphan/guaifenesin/pseudoephedrine 15 mg-200 mg-32 mg/5 mL oral liquid:
2 to 5 years: 2.5 mL orally 2 to 3 times daily not to exceed 4 mg/kg and up to a maximum of 60 mg of pseudoephedrine daily.
6 to 11 years: 5 mL orally 2 to 3 times daily not to exceed 3 doses daily..
12 years or older: 10 mL orally 2 to 3 times daily not to exceed 3 doses daily.

Dextromethorphan/guaifenesin/pseudoephedrine 15 mg-200 mg-30 mg/5 mL oral liquid:
12 years or older: 10 mL orally every 4 hours not to exceed 4 doses daily.

Dextromethorphan/guaifenesin/pseudoephedrine 15 mg-400 mg-45 mg oral tablet:
12 years or older: 1 tablet orally every 6 hours not to exceed 4 tablets daily.

Dextromethorphan/guaifenesin/pseudoephedrine 20 mg-400 mg-20 mg oral tablet:
6 to 11 years: 1/2 tablet orally every 4 to 6 hours not to exceed 3 tablets.
12 years or older: 1 tablet orally every 4 to 6 hours not to exceed 6 tablets daily.

Dextromethorphan/guaifenesin/pseudoephedrine 20 mg-400 mg-30 mg oral tablet:
6 to 11 years: 1/2 tablet orally every 4 to 6 hours not to exceed 3 tablets.
12 years or older: 1 tablet orally every 4 to 6 hours not to exceed 6 tablets daily.

Dextromethorphan/guaifenesin/pseudoephedrine 20 mg-400 mg-40 mg oral tablet:
6 to 11 years: 1/2 tablet orally every 4 to 6 hours not to exceed 3 tablets.
12 years or older: 1 tablet orally every 4 to 6 hours not to exceed 6 tablets daily.

Dextromethorphan/guaifenesin/pseudoephedrine 30 mg-575 mg-25 mg oral tablets, extended release:
2 to 5 years: 0.5 tablet orally every 12 hours not to exceed 1 tablet daily.
6 to 11 years: 1 tablet orally every 12 hours not to exceed 2 tablets daily.
12 years or older: 1 to 2 tablets orally every 12 hours not to exceed 4 tablets daily.

Dextromethorphan/guaifenesin/pseudoephedrine 30 mg-580 mg-60 mg oral tablet, extended release:
6 to 11 years: 0.5 tablet 2 times daily.
12 years or older: 1 to 2 tablets orally 2 times daily.

Dextromethorphan/guaifenesin/pseudoephedrine 30 mg-600 mg-50 mg oral tablets, extended release:
6 to 11 years: 1 tablet orally every 12 hours not to exceed 2 tablets daily.
12 years or older: 1 to 2 tablets orally every 12 hours not to exceed 4 tablets daily.

Dextromethorphan/guaifenesin/pseudoephedrine 4 mg-20 mg-10 mg/mL oral liquid:
1 to 2 months: 0.25 mL every 4 to 6 hours not to exceed 4 doses daily.
3 to 5 months: 0.5 mL every 4 to 6 hours not to exceed 4 doses daily.
6 to 11 months: 0.75 mL every 4 to 6 hours not to exceed 4 doses daily.
12 to 24 months: 1 mL every 4 to 6 hours not to exceed 4 doses daily.

Dextromethorphan/guaifenesin/pseudoephedrine 40 mg-700 mg-80 mg oral tablet, extended release:
6 to 11 years: 0.5 tablet orally every 12 hours.
12 years or older: 1 to 1.5 tablets orally every 12 hours.

Dextromethorphan/guaifenesin/pseudoephedrine 40 mg-780 mg-80 mg oral tablet, extended release:
6 to 11 years: 0.5 tablet orally 2 times daily.
12 years or older: 0.5 to 1.5 tablets orally 2 times daily. 1 tablet orally 3 times daily for maximum dosage.

Dextromethorphan/guaifenesin/pseudoephedrine 60 mg-800 mg-120 mg oral tablets, extended release:
6 to 11 years: 0.5 tablet orally every 12 hours not to exceed 1 tablet daily.
12 years or older: 1 tablet orally every 12 hours not to exceed 2 tablets daily.


What other drugs will affect dextromethorphan, guaifenesin, and pseudoephedrine?


Before taking dextromethorphan, guaifenesin, and pseudoephedrine, tell your doctor if you are using any of the following drugs:



  • celecoxib (Celebrex);




  • cinacalcet (Sensipar);




  • darifenacin (Enablex);




  • imatinib (Gleevec);




  • quinidine (Quinaglute, Quinidex);




  • ranolazine (Ranexa)




  • ritonavir (Norvir);




  • sibutramine (Meridia);




  • terbinafine (Lamisil);




  • medicines to treat high blood pressure; or




  • antidepressant medications such as amitriptyline (Elavil, Etrafon), bupropion (Wellbutrin, Zyban), fluoxetine (Prozac, Sarafem), fluvoxamine (Luvox), imipramine (Janimine, Tofranil), paroxetine (Paxil), sertraline (Zoloft), and others.



This list is not complete and there may be other drugs that can interact with dextromethorphan, guaifenesin, and pseudoephedrine. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.



More dextromethorphan, guaifenesin, and pseudoephedrine resources


  • Dextromethorphan, guaifenesin, and pseudoephedrine Side Effects (in more detail)
  • Dextromethorphan, guaifenesin, and pseudoephedrine Dosage
  • Dextromethorphan, guaifenesin, and pseudoephedrine Use in Pregnancy & Breastfeeding
  • Dextromethorphan, guaifenesin, and pseudoephedrine Drug Interactions
  • Dextromethorphan, guaifenesin, and pseudoephedrine Support Group
  • 5 Reviews for Dextromethorphan, guaifenesin, and pseudoephedrine - Add your own review/rating


Compare dextromethorphan, guaifenesin, and pseudoephedrine with other medications


  • Cough and Nasal Congestion


Where can I get more information?


  • Your pharmacist can provide more information about dextromethorphan, guaifenesin, and pseudoephedrine.

See also: dextromethorphan, guaifenesin, and pseudoephedrine side effects (in more detail)


Thursday, 25 June 2009

Tenoktil




Tenoktil may be available in the countries listed below.


Ingredient matches for Tenoktil



Tenoxicam

Tenoxicam is reported as an ingredient of Tenoktil in the following countries:


  • Turkey

  • Yemen

International Drug Name Search

Tuesday, 23 June 2009

Dosaflex


Generic Name: senna (SEN nah)

Brand Names: Black Draught, Dr Caldwell Laxative, Ex-Lax Chocolated, Ex-Lax Maximum Relief Formula, Ex-Lax Regular Strength Pills, Fletchers Castoria, Innerclean, Pedia-Lax, Perdiem Overnight, Senexon, Senna, Senna Lax, Senna Smooth, Senna Soft, Senna-gen, Senokot, Senokot Extra, SenokotXTRA, SenoSol, SenoSol-X


What is Dosaflex (senna)?

Senna is also known as Cassia senna, tinnevelly senna, India senna, Alexandrian senna, and Khartoum senna.


Senna has been used in alternative medicine as an aid to treat constipation.


Not all uses for senna have been approved by the FDA. Senna should not be used in place of medication prescribed for you by your doctor.

Senna is often sold as an herbal supplement. There are no regulated manufacturing standards in place for many herbal compounds and some marketed supplements have been found to be contaminated with toxic metals or other drugs. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination.


Senna may also be used for other purposes not listed in this product guide.


What is the most important information I should know about Dosaflex (senna)?


Not all uses for senna have been approved by the FDA. Senna should not be used in place of medication prescribed for you by your doctor.

Senna is often sold as an herbal supplement. There are no regulated manufacturing standards in place for many herbal compounds and some marketed supplements have been found to be contaminated with toxic metals or other drugs. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination.


Use senna as directed on the label, or as your healthcare provider has prescribed. Do not use this product in larger amounts or for longer than recommended.


Call your healthcare provider if your symptoms do not improve, or if they get worse while using senna. Do not use this product for longer than 1 week without the advice of a healthcare provider.

What should I discuss with my health care provider before taking Dosaflex (senna)?


Ask a doctor, pharmacist, herbalist, or other healthcare provider if it is safe for you to use this product if you have:



  • a bowel disorder such as Crohn's disease or ulcerative colitis;




  • heart disease; or




  • stomach pain, nausea, or vomiting.



Before using senna, talk to your doctor, pharmacist, herbalist, or other healthcare provider. You may not be able to use senna if you have any other medical conditions, allergies, or if you take other medicines or herbal/health supplements.


Do not take senna without first talking to your doctor if you are pregnant or could become pregnant. Do not take senna without first talking to your doctor if you are breast-feeding a baby. Some forms of senna are made for use by children. Do not give any herbal/health supplement to a child without the advice of a doctor.

How should I take Dosaflex (senna)?


When considering the use of herbal supplements, seek the advice of your doctor. You may also consider consulting a practitioner who is trained in the use of herbal/health supplements.


If you choose to use senna, use it as directed on the package or as directed by your doctor, pharmacist, or other healthcare provider. Do not use more of this product than is recommended on the label.


Senna is usually taken before bed to produce a bowel movement 6 to 12 hours later when you wake up.


Do not use different forms (such as tablets and liquid) of senna at the same time unless your healthcare provider tells you to. Call your healthcare provider if your symptoms do not improve, or if they get worse while using senna. Do not use this product for longer than 1 week without the advice of a healthcare provider. Store senna at room temperature away from moisture, heat, and light.

What happens if I miss a dose?


Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while taking Dosaflex (senna)?


Follow your healthcare provider's instructions about any restrictions on food, beverages, or activity.


Dosaflex (senna) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your healthcare provider at once if you have a serious side effect such as:

  • severe stomach pain, severe diarrhea, watery diarrhea;




  • weight loss;




  • worsening constipation after you stop taking senna;




  • enlargement of your fingers and toes;




  • low potassium (confusion, uneven heart rate, extreme thirst, increased urination, leg discomfort, muscle weakness or limp feeling); or




  • nausea, upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).



Less serious side effects may include:



  • stomach cramps, bloating, gas, mild diarrhea;




  • numbness or tingly feeling;




  • joint pain; or




  • discolored urine.



This is not a complete list of side effects and others may occur. Tell your doctor, pharmacist, herbalist, or other healthcare provider about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Dosaflex (senna)?


Do not take senna without the advice of a healthcare provider if you are using any of the following medications:

  • digoxin (Lanoxin);




  • a diuretic (water pill); or




  • a blood thinner such as warfarin (Coumadin).



This list is not complete and other drugs may interact with senna. Tell your healthcare provider about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Dosaflex resources


  • Dosaflex Side Effects (in more detail)
  • Dosaflex Use in Pregnancy & Breastfeeding
  • Dosaflex Drug Interactions
  • Dosaflex Support Group
  • 0 Reviews for Dosaflex - Add your own review/rating


  • Senna Natural MedFacts for Professionals (Wolters Kluwer)

  • Senna Professional Patient Advice (Wolters Kluwer)

  • Senna Natural MedFacts for Consumers (Wolters Kluwer)

  • Senna Monograph (AHFS DI)

  • Senexon Liquid MedFacts Consumer Leaflet (Wolters Kluwer)

  • Senokot MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Dosaflex with other medications


  • Bowel Preparation
  • Constipation


Where can I get more information?


  • Consult with a licensed healthcare professional before using any herbal/health supplement. Whether you are treated by a medical doctor or a practitioner trained in the use of natural medicines/supplements, make sure all your healthcare providers know about all of your medical conditions and treatments.

See also: Dosaflex side effects (in more detail)